Li Lin

机构：Jiangsu University, Guangzhou University of Chinese Medicine, Nanchang University, Sun Yat-sen University, Beijing University of Chinese Medicine, Wuhan University of Technology, Sichuan University, Wenzhou Medical University, West China Hospital of Sichuan University, Jiangxi Provincial Cancer Hospital, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Second Affiliated Hospital of Nanchang University, Jiangsu Cancer Hospital, Center of Hubei Cooperative Innovation for Emissions Trading System, Dongfeng Motor Group (China), Shenzhen Second People's Hospital, Beijing University of Chemical Technology, Zhejiang University

发表论文 1045 篇 · 总被引 29862 次 · h-index 79

代表论文

• Phospholipids tailor mRNA lipid nanoparticle delivery efficacy and immunogenicity (2026 · Materials Today · 被引 6)
• Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic ductal adenocarcinoma (2025 · Journal of Nanobiotechnology · 被引 6)
• Effects of soil organic amendments on soil organic carbon content and molecular diversity at the aggregate level (2026 · Ecotoxicology and Environmental Safety · 被引 3)
• NAT10-mediated ac4C modifications regulate glioblastoma progression (2026 · Cell Death and Disease · 被引 2)
• Clinical characteristics and prognostic factors of pediatric acute eosinophilic pneumonia: an 11-year single-center retrospective cohort study (2026 · European Journal of Pediatrics · 被引 2)
• Prenylterphenyllin, a regulator of P53, inhibits colorectal cancer progression through oxidative stress and energy metabolism pathway (2026 · Redox Biology · 被引 2)